Social Media Ideas for Celiac Disease

Latest updates for Celiac Disease

Fresh curated links around celiac disease are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

medicalxpress.com /1 month ago

Gluten-free diet reshapes gut bacteria after celiac diagnosis in children

Celiac disease is an autoimmune condition triggered by gluten that affects 1% to 3% of people globally and is caused by a mix of known genetic factors and unknown environmental one...

Read source

snacksafely.com /5 days ago

Potential Breakthrough for Celiac Disease: Teva Antibody Significantly Reduces Gluten-Induced Gut Damage

A single dose of Teva’s experimental antibody significantly reduced gluten-induced intestinal damage and inflammation in a Phase 2 celiac disease trial. The post Potential Breakthr...

Read source

medcitynews.com /6 days ago

Teva Drug Rises to the Gluten Challenge, Stopping Intestinal Damage in Celiac Disease Trial

In a mid-stage study, Teva’s drug prevented intestinal damage in celiac disease patients who underwent a gluten challenge — eating food with gluten to see if it prompts an immune r...

Read source

kevinmd.com /1 week ago

Celiac disease in college: 3 skills to build first

Every year, families celebrate college acceptances while quietly worrying about something that has little to do with academics, roommates, or move-in day logistics. Their concern i...

Read source

aftenposten.no /1 month ago

«Cøliaki er kjipt», skriver Geir Kulia. Det er riktigere å si at cøliaki er en alvorlig autoimmun sykdom.

Svarer om cøliaki.

Read source

fiercebiotech.com /1 month ago

Takeda scraps another phase 2 celiac disease therapy, narrowing pipeline to one

Takeda has dropped another celiac disease therapy from its phase 2 pipeline, leaving the company with just one shot at treating the condition.

Read source

fiercebiotech.com /1 week ago

Teva autoimmune antibody notches ph. 2 win in celiac disease

Teva Pharmaceutical's dreams of a first-in-class autoimmune blockbuster are being kept alive after the Israeli outfit’s anti-interleukin-15 antibody scored a midstage win in celiac...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.